110 related articles for article (PubMed ID: 31764012)
1. Antitumor activity of a hydrogel loaded with lipophilic bismuth nanoparticles on cervical, prostate, and colon human cancer cells.
Cabral-Romero C; Solís-Soto JM; Sánchez-Pérez Y; Pineda-Aguilar N; Meester I; Pérez-Carrillo E; Nakagoshi-Cepeda SE; Sánchez-Nájera RI; Nakagoshi-Cepeda MAA; Hernandez-Delgadillo R; Chellam S; García-Cuéllar CM
Anticancer Drugs; 2020 Mar; 31(3):251-259. PubMed ID: 31764012
[TBL] [Abstract][Full Text] [Related]
2. In vitro evaluation of the antitumor effect of bismuth lipophilic nanoparticles (BisBAL NPs) on breast cancer cells.
Hernandez-Delgadillo R; García-Cuéllar CM; Sánchez-Pérez Y; Pineda-Aguilar N; Martínez-Martínez MA; Rangel-Padilla EE; Nakagoshi-Cepeda SE; Solís-Soto JM; Sánchez-Nájera RI; Nakagoshi-Cepeda MAA; Chellam S; Cabral-Romero C
Int J Nanomedicine; 2018; 13():6089-6097. PubMed ID: 30323596
[TBL] [Abstract][Full Text] [Related]
3. Peptidyl membrane-interactive molecules are cytotoxic to prostatic cancer cells in vitro.
Robertson CN; Roberson KM; Pinero A; Jaynes JM; Paulson DF
World J Urol; 1998; 16(6):405-9. PubMed ID: 9870289
[TBL] [Abstract][Full Text] [Related]
4. Bismuth Lipophilic Nanoparticles (BisBAL NP) Inhibit the Growth of Tumor Cells in a Mouse Melanoma Model.
García-Cuellar CM; Cabral-Romero C; Hernández-Delgadillo R; Solis-Soto JM; Meester I; Sánchez-Pérez Y; Nakagoshi-Cepeda SE; Pineda-Aguilar N; Sánchez-Nájera RI; Nakagoshi-Cepeda MAA; Chellam S
Anticancer Agents Med Chem; 2022; 22(14):2548-2557. PubMed ID: 35168526
[TBL] [Abstract][Full Text] [Related]
5. Effect of 1-Carbaldehyde-3,4-dimethoxyxanthone on Prostate and HPV-18 Positive Cervical Cancer Cell Lines and on Human THP-1 Macrophages.
Medeiros R; Horta B; Freitas-Silva J; Silva J; Dias F; Sousa E; Pinto M; Cerqueira F
Molecules; 2021 Jun; 26(12):. PubMed ID: 34207168
[TBL] [Abstract][Full Text] [Related]
6. Docetaxel-loaded PAMAM-based poly (γ-benzyl-l-glutamate)-b-d-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles in human breast cancer and human cervical cancer therapy.
Wang Y; Zuo A; Huang X; Ying Y; Shu X; Chen X; Yang Y; Ma J; Lin G; Wang X; Mei L; Liu G; Zhao Y
J Microencapsul; 2019 Sep; 36(6):552-565. PubMed ID: 31403342
[TBL] [Abstract][Full Text] [Related]
7. Cumulative antitumor effect of bismuth lipophilic nanoparticles and cetylpyridinium chloride in inhibiting the growth of lung cancer.
García-Cuellar CM; Hernández-Delgadillo R; Torres-Betancourt JA; Solis-Soto JM; Meester I; Sánchez-Pérez Y; Pineda-Aguilar N; Nakagoshi-Cepeda SE; Sánchez-Nájera RI; Nakagoshi-Cepeda MAA; Chellam S; Cabral-Romero C
J Appl Biomater Funct Mater; 2023; 21():22808000231161177. PubMed ID: 36942951
[TBL] [Abstract][Full Text] [Related]
8. Multifunctional Bismuth Selenide Nanocomposites for Antitumor Thermo-Chemotherapy and Imaging.
Li Z; Hu Y; Howard KA; Jiang T; Fan X; Miao Z; Sun Y; Besenbacher F; Yu M
ACS Nano; 2016 Jan; 10(1):984-97. PubMed ID: 26655250
[TBL] [Abstract][Full Text] [Related]
9. Doxorubicin-loaded functionalized selenium nanoparticles for enhanced antitumor efficacy in cervical carcinoma therapy.
Xia Y; Xiao M; Zhao M; Xu T; Guo M; Wang C; Li Y; Zhu B; Liu H
Mater Sci Eng C Mater Biol Appl; 2020 Jan; 106():110100. PubMed ID: 31753388
[TBL] [Abstract][Full Text] [Related]
10. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon.
Wu P; Zhou Q; Zhu H; Zhuang Y; Bao J
BMC Cancer; 2020 Apr; 20(1):354. PubMed ID: 32345258
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity, qualitative structure-activity relationship (QSAR), and anti-tumor activity of bismuth dithiocarbamate complexes.
Li H; Lai CS; Wu J; Ho PC; de Vos D; Tiekink ER
J Inorg Biochem; 2007 May; 101(5):809-16. PubMed ID: 17363061
[TBL] [Abstract][Full Text] [Related]
12. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer.
Li C; Ge X; Wang L
Biomed Pharmacother; 2017 Feb; 86():628-636. PubMed ID: 28027539
[TBL] [Abstract][Full Text] [Related]
13. SPIONs/3D SiSBA-16 based Multifunctional Nanoformulation for target specific cisplatin release in colon and cervical cancer cell lines.
Jermy BR; Alomari M; Ravinayagam V; Almofty SA; Akhtar S; Borgio JF; AbdulAzeez S
Sci Rep; 2019 Oct; 9(1):14523. PubMed ID: 31601952
[TBL] [Abstract][Full Text] [Related]
14. Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies.
Chaurasia S; Chaubey P; Patel RR; Kumar N; Mishra B
Drug Dev Ind Pharm; 2016; 42(5):694-700. PubMed ID: 26165247
[TBL] [Abstract][Full Text] [Related]
15. Antitumor efficiency of D-alpha-tocopheryl polyethylene glycol 1000 succinate-b-poly(epsilon-caprolactone-ran-lactide) nanoparticle-based delivery of docetaxel in mice bearing cervical cancer.
Wang Z; Zeng X; Ma Y; Liu J; Tang X; Gao Y; Liu K; Zhang J; Ming P; Huang L; Mei L
J Biomed Nanotechnol; 2014 Aug; 10(8):1509-19. PubMed ID: 25016651
[TBL] [Abstract][Full Text] [Related]
16. PNAS-4, a novel pro-apoptotic gene, can potentiate antineoplastic effects of cisplatin.
Yuan Z; Yan F; Wang YS; Liu HY; Gou LT; Zhao XY; Lai ST; Deng HX; Li J; Ding ZY; Xiong SQ; Kan B; Mao YQ; Chen LJ; Wei YQ; Zhao X
Cancer Chemother Pharmacol; 2009 Dec; 65(1):13-25. PubMed ID: 19387645
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic Effect of Lipophilic Bismuth Dimercaptopropanol Nanoparticles on Epithelial Cells.
Rene HD; Badireddy AR; José MS; Francisco CC; Israel MG; Isela SN; Chellam S; Claudio CR
J Nanosci Nanotechnol; 2016 Jan; 16(1):203-9. PubMed ID: 27398446
[TBL] [Abstract][Full Text] [Related]
18. Tumor targeted, stealthy and degradable bismuth nanoparticles for enhanced X-ray radiation therapy of breast cancer.
Deng J; Xu S; Hu W; Xun X; Zheng L; Su M
Biomaterials; 2018 Feb; 154():24-33. PubMed ID: 29120816
[TBL] [Abstract][Full Text] [Related]
19. Physicochemical Characterization of Curcumin Loaded Chitosan Nanoparticles: Implications in Cervical Cancer.
Khan MA; Zafaryab M; Mehdi SH; Ahmad I; Rizvi MMA
Anticancer Agents Med Chem; 2018; 18(8):1131-1137. PubMed ID: 29651963
[TBL] [Abstract][Full Text] [Related]
20. The conjugates of forky peptides and nonsteroidal anti-inflammatory drugs (NSAID) self-assemble into supramolecular hydrogels for prostate cancer-specific drug delivery.
Tao M; He S; Liu J; Li H; Mei L; Wu C; Xu K; Zhong W
J Mater Chem B; 2019 Jan; 7(3):469-476. PubMed ID: 32254734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
